On March 15, 2022, Talis Biomedical Corporation announced that Douglas Liu will be stepping down as the Company's Chief Operating Officer, effective April 15, 2022. The Company presently does not intend to fill the position of Chief Operating Officer. Instead, upon Mr. Liu's departure, his responsibilities will be transitioned to other parts of the Company's organization, each of which will ultimately report to the Company's Chief Executive Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.15 USD | +1.36% | -0.54% | +22.82% |
05-08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | North American Morning Briefing : Stocks Seen -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+22.82% | 16.67M | |
+51.85% | 57.87B | |
+41.36% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- TLIS Stock
- News Talis Biomedical Corporation
- Douglas Liu to Step Down as Chief Operating Officer of Talis Biomedical Corporation, Effective April 15, 2022